Cardinal Health (CAH)
(Delayed Data from NYSE)
$98.91 USD
-4.07 (-3.95%)
Updated May 3, 2024 04:00 PM ET
After-Market: $98.90 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Price, Consensus and EPS Surprise
CAH 98.91 -4.07(-3.95%)
Will CAH be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for CAH based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CAH
Compared to Estimates, Cardinal (CAH) Q3 Earnings: A Look at Key Metrics
Cardinal Health (CAH) Beats on Q3 Earnings, Ups '24 EPS View
CAH: What are Zacks experts saying now?
Zacks Private Portfolio Services
What You Should Know About Block (SQ) Ahead of Q1 Earnings
What You Should Do With MercadoLibre (MELI) Ahead of Q1 Earnings
What's in Store for These 5 Medical Device Stocks in Q1 Earnings?
Other News for CAH
Unveiling Cardinal Health (CAH)'s Value: Is It Really Priced Right? A Comprehensive Guide
5 Expected Dividend Increases In May 2024
This Is What Whales Are Betting On Cardinal Health
Analysts Offer Insights on Healthcare Companies: Cardinal Health (CAH), Kura Oncology (KURA) and Amgen (AMGN)
Cardinal Health price target lowered by $6 at Baird, here's why